Skip to content
Cyclodextrin News

Cyclodextrin News

A forum for researchers, students and applicants in the field of cyclodextrin technology

  • Home
  • Pharma applications
  • Non-pharma applications
  • CD derivatives
  • Events
  • E-ducation

Tag: siRNA

August 26, 2025 CD as API / Drug delivery / Pharma applications

Cyclodextrin-Based Nanotransporters as a Versatile Tool to Manage Oxidative Stress-Induced Lung Diseases

Oxidative stress is one of the key elements in lung-related complications such as cystic fibrosis, acute lung injury, pulmonary hypertension,

Continue reading

October 12, 2023 Drug delivery / Pharma applications

Cyclodextrin-Based Arsenal for Anti-Cancer Treatments

Anti-cancer drugs are mostly limited in their use due to poor physicochemical and biopharmaceutical properties. Their lower solubility is the

Continue reading

March 2, 2023 Drug delivery / Pharma applications

Cyclodextrin-Based Arsenal for Anti-Cancer Treatments

After a recent review on applicatipon of CD-based systems in cancer therapy a new review has been published by Kushik’s

Continue reading

January 2, 2019 CD as API / CD derivatives / Cosmetics and toilettry / Drug delivery / Gene delivery / Non-pharma applications / Pharma applications

Cyclodextrin News Year in Review 2018

The CDNews blog was created in July and after a short period of trial it started in September. During this

Continue reading

December 1, 2018 CD derivatives / Gene delivery / Pharma applications

Antibody-Targeted Cyclodextrin-Based Nanoparticles for siRNA Delivery

In the laboratory of C. M. O’Driscoll (University College Cork), an antibody targeted cyclodextrin-based siRNA delivery vector (CD.DSPE-PEGFab) was developed

Continue reading

September 18, 2018 CD derivatives / Gene delivery / Pharma applications

Bridging cyclodextrin to transfect siRNA

The bridging of beta-cyclodextrin with an ammonium linker which bears a hydrophobic substituent efficiently forms supramolecular polymers, avoiding the competing

Continue reading

Recent Posts

  • HPBCD-enhanced Vaginal Hydrogel: Innovative Treatment for Menopause Symptoms
  • Association of Sugammadex Exposure with Venous Thrombosis Risk Following Primary Total Knee Arthroplasty: A Multi-Institutional Retrospective Analysis
  • Special Issue titled “Cyclodextrins: Properties and Applications, 4th Edition”
  • Cyclodextrins hit the golf course seven years ago — and they are still there
  • Enhancing Curcumin Efficacy Against Triple-Negative Breast Cancer

Tags

alpha-CD atherosclerosis Cancer therapy Captisol Cholesterol Clinical trial conference Covid-19 cyclodextrin polymer Dexolve drug delivery drug delivery systems electrospinning FDA Food gamma-CD Gilead HPBCD hydrogel methyl BCD Nanoparticles Niemann Pick Disease RAMEB remdesivir review SBECD Special issue Sugammadex Synthesis

Follow Us

  • LinkedIn
  • X
  • Facebook

Categories

  • Agriculture (27)
  • Analysis (73)
  • CD as API (356)
  • CD derivatives (431)
  • Cosmetics and toilettry (54)
  • Diagnosis (15)
  • Drug delivery (817)
  • E-ducation (63)
  • Environmental (143)
  • Events (239)
  • Food (233)
  • Gene delivery (22)
  • Household products (6)
  • In Hungarian (4)
  • Life sciences (45)
  • Non-pharma applications (416)
  • Other industrial use (112)
  • Pharma applications (1,221)
  • Supramolecular systems (44)
  • Uncategorized (167)

Top Posts

  • HPBCD-enhanced Vaginal Hydrogel: Innovative Treatment for Menopause Symptoms
  • Association of Sugammadex Exposure with Venous Thrombosis Risk Following Primary Total Knee Arthroplasty: A Multi-Institutional Retrospective Analysis
  • Phosphorylated Beta-cyclodextrin as a New Bone-Targeting Drug Delivery System Could Change the Treatment of Osteoporosis and Other Bone Diseases
  • MANU-KAMU - Dog dental treats with cyclodextrin
  • Reducing Cholesterol with β-CDP: Insights for NPC and AD
  • Cyclodextrins hit the golf course seven years ago — and they are still there
  • Beyond Cholesterol: New Review Examines 7-Ketocholesterol and Its Role in Disease
  • Synthesis and potential applications of cyclodextrin-based metal–organic frameworks: a review
  • Piroxicam/Cyclodextrin: 35 years on the market
  • New FDA approved medicinal product containing Betadex sulfobutylether sodium: VYKOURA

Subscribe to Blog via Email

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Join 4,476 other subscribers
Loading Comments...